Genetic Markers of Cardiovascular Disease - H. Robert Superko, M.D.

Cardiovascular disease (CVD) remains the leading cause death in the USA. CVD is now considered to be an interaction between genetic susceptibility and environmental lifestyle issues. Practical clinical utility of inherited cardiovascular risk testing does exist utilizing both phenotypes and genotypes and includes improved CHD risk prediction and early CHD detection, selection of a treatment most likely to be successful in an era of personalized medicine includes genetic susceptibility and the clinical role of currently available tests. Dr. Superko will also discuss the practical implications of genetic tests including 9p21, 4q25, SLCO1B1, ApoE, and others.

What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.

About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.

For more information visit http://www.agemed.org